In October 2017, the Clinical Journal of Nursing Oncology published a “Multiple Myeloma” supplement authored by the International Myeloma Foundation’s Nurse Leadership Board. This supplement provides downloadable PDFs of research-based articles on myeloma symptoms and complications and their management. Each article includes an activity for CNE credit. Also included are educational tips sheetsfor patients and healthcare providers. Read more about these resources below.
Articles Available for Download
Patients with multiple myeloma cope with short- and long-term side effects of treatment and consequences of the disease itself. This article discusses the many reasons for inadequate management of symptoms, such as patients fearing treatment interruption or the clinician not properly assessing or addressing symptoms.
The psychological needs of multiple myeloma patients and their caregivers might be overlooked. As a result, patients may experience distress and suffer compromising outcomes. If these psychological needs are untreated, a multiple myeloma patient’s ability to make decisions and adhere to treatment could be impaired. This article aims to guide oncology nurses to recognize and manage distress, fatigue, and sexual dysfunction in patients with multiple myeloma.
Many multiple myeloma patients may “experience damage to the kidneys and peripheral nerves at diagnosis or throughout the course of the disease.” They face “symptoms of diarrhea, nausea, vomiting, or constipation.” This article aims “to provide insight into the prevention and management or organ health-related toxicities and give best practice recommendations for optimal nursing care.”
Multiple myeloma patients may experience venous thromboembolism (VTE) and cardiovascular (CV) disease. VTE and CV are separate medical conditions; however, they can both be “serious and life-threatening.” This article describes “the influence of CV disease on patients with multiple myeloma.” It also reviews how to identify and treat these conditions.
About 85% of multiple myeloma patients develop bone disease. Bone disease is characterized by the presence of lytic bone lesions. In multiple myeloma patients, these lesions may cause “fractures, poor circulation, blood clots, pain, poor mobility, and decreased quality of life.” This article aims to guide nurses “in the assessment and management of bone disease, pain, and mobility in patients with multiple myeloma at varying points in their disease trajectory.”
Multiple myeloma and its treatment may lead to potentially life-threatening conditions that require immediate medical attention. These oncological emergencies may include myelosuppression (anemia, neutropenia, and thrombocytopenia), bone-related emergencies, and acute renal failure. This article reviews “the pathophysiology of these multiple myeloma-associated oncology emergencies and provides a framework for assessment and effective intervention.”
About the Nurse Leadership Board
The International Myeloma Foundation (IMF) Nurse Leadership Board® (NLB) is a professional partnership representing nurse experts from leading medical centers caring for myeloma patients. The NLB’s primary mission is to improve the nursing care and self-care of patients with myeloma by educating nurses and patients via publications, symposia, multimedia, and research.